Racial-Ethnic Disparities in Outpatient Mental Health Care in the United States
Abstract
Objective:
The authors aimed to compare national rates and patterns of use of outpatient mental health care among Hispanic, non-Hispanic Black, and non-Hispanic White individuals.
Methods:
Data from the 2018–2019 Medical Expenditure Panel Survey, a nationally representative survey of U.S. households, were analyzed, focusing on use of any outpatient mental health care service by non-Hispanic White (N=29,126), non-Hispanic Black (N=7,965), and Hispanic (N=12,640) individuals ages ≥4 years (N=49,731). Among individuals using any mental health care, analyses focused on those using psychotropic medications, psychotherapy, or both and on receipt of minimally adequate mental health care.
Results:
The annual rate per 100 persons of any outpatient mental health service use was more than twice as high for White (25.3) individuals as for Black (12.2) or Hispanic (11.4) individuals. Among those receiving outpatient mental health care, Black (69.9%) and Hispanic (68.4%) patients were significantly less likely than White (83.4%) patients to receive psychotropic medications, but Black (47.7%) and Hispanic (42.6%) patients were significantly more likely than White (33.3%) patients to receive psychotherapy. Among those treated for depression, anxiety, attention-deficit hyperactivity disorder, or disruptive behavior disorders, no significant differences were found in the proportions of White, Black, or Hispanic patients who received minimally adequate treatment.
Conclusions:
Large racial-ethnic gaps in any mental health service use and smaller differences in patterns of treatment suggest that achieving racial-ethnic equity in outpatient mental health care delivery will require dedicated efforts to promote greater mental health service access for Black and Hispanic persons in need.
HIGHLIGHTS
•
In the United States, non-Hispanic Black and Hispanic individuals are approximately half as likely to receive outpatient mental health care as non-Hispanic White individuals.
•
Among those receiving care, Black and Hispanic people are less likely than White people to receive psychotropic medications and more likely to receive psychotherapy.
•
A dedicated national commitment is needed to close the large racial-ethnic gaps in access to outpatient mental health care.
In the United States, studies have shown that non-Hispanic Black and Hispanic individuals are less likely than non-Hispanic White individuals to receive outpatient mental health care (1, 2). Key drivers of these differences are thought to operate through systemic and social factors, including structural racism and discrimination (3) at individual, community, and population levels (4). One pathway through which structural racism might adversely affect access to mental health care is through diminished opportunities for financial advancement and lower availability of resources, as reflected in education, employment, income, and health insurance (5). Yet, little is known about recent national racial-ethnic patterns in outpatient mental health care and their relationship to socioeconomic status (6). Although reducing racial-ethnic differences in mental health service access would decrease downstream disparities in mental health care delivery, after entering treatment, Black and Hispanic patients may also receive less intensive or less effective mental health care than White patients (7, 8).
The current evidence concerning differences in minimally adequate mental health care shows stronger and more consistent disparities between Blacks and Whites than between Hispanics and Whites (8–10). The Health Care for Communities Survey found that Black patients with probable depressive or anxiety disorders were less than half as likely as White patients to receive minimally adequate mental health care (10). The Midlife Development in the United States Survey (8) and the National Comorbidity Survey–Replication (9) yielded similar results. More recently, commercially insured Black patients who received psychotherapy were reported to receive fewer sessions than their White counterparts (11).
In this study, we aimed to update national population-based estimates of outpatient mental health care for Black, Hispanic, and White people in the United States and reassess their relationship to socioeconomic status. Among individuals receiving mental health treatment, we also report racial-ethnic differences in patterns and adequacy of care. A greater understanding of these two aspects of mental health care might inform efforts to address drivers of racial-ethnic disparities in care. We anticipated that Hispanic and Black individuals would be less likely than White individuals to receive outpatient mental health care and, among those receiving care, that Hispanic and Black patients would be less likely than White patients to receive minimally adequate care.
Methods
Data Sources
Data were analyzed from the 2018–2019 Medical Expenditure Panel Survey (MEPS) of U.S. households conducted by the Agency for Healthcare Research and Quality. Technical information concerning the fielding and nonresponse adjustment of the MEPS is provided in previous studies (12, 13). The MEPS was administered in English and Spanish by computer-assisted personal interviewing. A new nationally representative sample of households is selected each year, and participants are interviewed five times over a 2-year period to improve the recall of service use. The MEPS had full-year response rates of 42.7% in 2018 and 39.5% in 2019, with >90% of surveys administered in person, and oversampled Black and Hispanic individuals.
Study Samples
The first analytic sample included all individuals in the household survey sample, ages ≥4 years, from the three racial-ethnic groups of interest to this study (N=49,731). Within this sample, we examined racial-ethnic differences in rates of any outpatient mental health care use. The second sample was limited to people who used outpatient mental health care. This sample was examined for racial-ethnic differences in the type of outpatient mental health care used and whether individuals received minimally adequate care.
Mental Health Service Outcomes
Mental health service outcomes included any outpatient mental health care and, among people with outpatient mental health care, included receipt of psychotropic medication, psychotherapy, or both and receipt of minimally adequate treatment. Outpatient mental health care was defined as having at least one visit with a psychiatric diagnosis (ICD-10-CM codes F10–F69 and F90–F99); at least one visit to a psychiatrist, social worker, psychologist, or mental health counselor; or prescription of at least one psychotropic medication for a mental health condition. Because psychological distress is commonly diagnosed outside of specialty mental health settings (14–16) where F codes may not be used, outpatient visits with other selected ICD-10-CM codes (i.e., for insomnia, substance use counseling, life management difficulties, social skill inadequacy, attention and concentration deficits, stress, fatigue, and postpartum mood disturbance) were included as evidence of outpatient mental health care (see Table S1 in the online supplement to this article).
Psychotherapy was defined as “a treatment technique for certain forms of mental disorders relying principally on talk/conversation between the mental health professional and the patient.” It specifically included “individual, family, and/or group therapies” (17). Psychotropic medications included antidepressants, antipsychotics, anxiolytics and hypnotics, stimulants or other medications for attention-deficit hyperactivity disorder (ADHD), and mood stabilizers obtained from pharmacies during the survey year (see Table S2 in the online supplement ). To facilitate comparison with previous research, we defined minimally adequate care as having at least eight visits to a mental health provider during the study year or having at least four visits to any provider and receiving prescribed antidepressants (for depression and anxiety), an anxiolytic or hypnotic medication (anxiety), or a stimulant or other ADHD medication (ADHD or disruptive behavior disorder) (8–10).
Mental Health Conditions and Other Characteristics
The MEPS collected information on psychiatric conditions for each outpatient visit, and professional coders assigned ICD-10-CM categories (18). Mental health conditions included mood disorders with a depression subgroup, anxiety disorders, trauma- and stress-related disorders, ADHD and other disruptive behavior disorders, other mental disorders, and mental health–related conditions (see Table S1 in the online supplement ). Other characteristics included age in years, sex, marital status, educational attainment, family income, health insurance, employment status, and perceived mental health status (excellent, very good, good, fair, or poor).
Statistical Analysis
A preliminary analysis compared the background characteristics of White, Black, and Hispanic persons ages ≥4 years (see Table S3 in the online supplement ). This analysis was followed by a comparison, by racial-ethnic group, of annual rates of any outpatient mental health care overall and stratified by age group and sex. Differences in rates and associated 95% CIs were calculated and adjusted for perceived mental health status. In these analyses, we withheld adjustment for other sociodemographic characteristics, such as income or education, which may mediate the association between race-ethnicity and the mental health care outcomes (19–21). Stepped regressions were fit with race-ethnicity as the independent variable of interest and any outpatient mental health care as the dependent variable. After unadjusted regressions, age, sex, and perceived mental health status were stepped in, followed by education, income, health insurance, and employment. Among individuals receiving outpatient mental health care (hereafter “patients”), the racial-ethnic groups were compared with respect to sociodemographic characteristics and clinical background. Next, the racial-ethnic patient groups were compared with respect to the proportions of individuals receiving psychotherapy, psychotropic medication, or both, controlling for age, sex, and perceived mental health status by using adjusted mean differences. Finally, the racial-ethnic patient groups treated for depression, anxiety, and ADHD or disruptive behavior disorders were compared with respect to receiving selected psychotropic medications and adequate mental health treatment. In sensitivity analyses, these regressions were also controlled for health care coverage. In evaluating the results, it is important to bear in mind that race and ethnicity are imprecise social constructs without biological meaning (22).
All statistical analyses were performed in R, version 4.1.2, by using the survey package, version 4.0, to accommodate the complex sample design and weighting of observations. The institutional review board of the New York State Psychiatric Institute exempted this analysis from human subjects review.
Results
Annual Rates of Outpatient Mental Health Care Utilization
In the overall national population (White, N=29,126; Black, N=7,965; and Hispanic, N=12,640 [Table 1]), fair or poor perceived mental health was significantly less common among Hispanic (6.7%) than White (7.9%) individuals but similar to Black (7.5%) individuals (percentages are weighted percentages; see Table S3 in the online supplement ). The annual unadjusted rate of outpatient mental health care utilization was more than twice as high for White (25.3 per 100 persons) as for Black (12.2 per 100 persons) or Hispanic (11.4 per 100 persons) individuals (Table 1). In analyses adjusted for perceived mental health status, White males and females in each age group had significantly higher rates of outpatient mental health care compared with their Black counterparts (Table 1). Similarly, compared with Hispanic people, White individuals had significantly higher rates of outpatient mental health care. For all ages and among individuals ages 18–44 and 45–64 years, Black men had higher rates of outpatient mental health care than Hispanic men, but the reverse was true for men ages ≥65.
| Receipt of outpatient mental health care per 100 persons | White-Black comparisonb | White-Hispanic comparisonb | Black-Hispanic comparisonb | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Characteristic | White | Black | Hispanic | Difference (percentage points) | 95% CI | Difference (percentage points) | 95% CI | Difference (percentage points) | 95% CI |
| Total (White, N=29,126; Black, N=7,965; Hispanic, N=12,640) | 25.3 | 12.2 | 11.4 | 12.7 | 11.4, 14.0 | 13.5 | 12.3, 14.7 | .8 | −.7, 2.2 |
| Male | |||||||||
| Total (White, N=14,164; Black, N=3,524; Hispanic, N=5,994) | 19.4 | 10.9 | 9.2 | 8.2 | 6.4, 10.0 | 10.0 | 8.5, 11.4 | 1.8 | .2, 3.8 |
| Ages 4–17 (White, N=2,390; Black, N=835; Hispanic, N=1,862) | 17.9 | 12.3 | 11.0 | 6.2 | 2.3, 10.0 | 7.7 | 5.0, 10.5 | 1.5 | −2.6, 5.7 |
| Ages 18–44 (White, N=4,242; Black, N=1,184; Hispanic, N=2,321) | 18.6 | 9.2 | 6.4 | 8.4 | 6.0, 10.8 | 11.3 | 9.2, 13.3 | 2.9 | .4, 5.4 |
| Ages 45–64 (White, N=3,955; Black, N=931; Hispanic, N=1,305) | 19.6 | 12.5 | 9.4 | 7.5 | 4.5, 10.4 | 10.8 | 8.0, 13.5 | 3.3 | .2, 6.4 |
| Ages ≥65 (White, N=3,577; Black, N=574; Hispanic, N=506) | 21.8 | 10.7 | 18.8 | 13.1 | 9.7, 16.6 | 6.5 | .9, 12.1 | −6.6 | −12.6, .6 |
| Female | |||||||||
| Total (White, N=14,962; Black, N=4,441; Hispanic, N=6,646) | 30.9 | 13.2 | 13.6 | 17.1 | 15.6, 18.7 | 16.8 | 15.1, 18.5 | −.3 | −2.0, 1.3 |
| Ages 4–17 (White, N=2,195; Black, N=851; Hispanic, N=1,736) | 16.5 | 7.7 | 7.9 | 7.8 | 5.0, 10.5 | 8.2 | 5.5, 10.9 | .4 | −2.3, 3.2 |
| Ages 18–44 (White, N=4,330; Black, N=1,509; Hispanic, N=2,657) | 30.0 | 12.0 | 13.3 | 16.0 | 13.2, 18.8 | 15.2 | 12.6, 17.8 | −.8 | −3.3, 1.7 |
| Ages 45–64 (White, N=4,336; Black, N=1,263; Hispanic, N=1,538) | 35.9 | 17.6 | 17.6 | 20.3 | 17.4, 23.1 | 20.7 | 17.3, 24.0 | .4 | −3.2, 4.0 |
| Ages ≥65 (White, N=4,101; Black, N=818; Hispanic, N=715) | 34.8 | 16.3 | 22.3 | 20.7 | 17.4, 24.0 | 16.4 | 12.4, 20.3 | −4.3 | −9.1, .4 |
a
Source: 2018–2019 Medical Expenditure Panel Survey, sample members ages ≥4 years. Black denotes non-Hispanic Black, and White denotes non-Hispanic White. Percentages are based on weighted sampling.
b
Differences were adjusted for perceived mental health status and were calculated by subtracting the rate of receiving annual outpatient mental health care of the second-listed racial-ethnic group from the rate of the first-listed racial-ethnic group.
Socioeconomic Mediation of Racial-Ethnic Differences in Outpatient Care
In the stepped regression analyses, differences in outpatient mental health care utilization between Black and White individuals and between Hispanic and White people changed little after we controlled for age, sex, perceived mental health status, education level, family income, health insurance, and employment status (Table 2).
| Unadjusted | Partially adjustedb | Fully adjustedc | ||||
|---|---|---|---|---|---|---|
| Characteristic | Difference (percentage points) | 95% CI | Difference (percentage points) | 95% CI | Difference (percentage points) | 95% CI |
| Non-Hispanic Black (reference: non-Hispanic White) | −13.1 | −14.5, −11.7 | −12.6 | −13.9, −11.3 | −12.0 | −13.3, −10.6 |
| Hispanic (reference: non-Hispanic White) | −13.8 | −15.1, −12.6 | −12.8 | −14.0, −11.6 | −11.0 | −12.3, −9.7 |
a
Source: 2018–2019 Medical Expenditure Panel Survey, sample members ages ≥4 years. Percentages are based on weighted sampling.
b
Partially adjusted for racial-ethnic group, age, sex, and perceived mental health status.
c
Fully adjusted for racial-ethnic group, age, sex, perceived mental health status, education level, family income, health insurance, and employment status.
Characteristics of People Using Outpatient Mental Health Care
In unadjusted analyses, several sociodemographic and clinical differences emerged among White, Black, and Hispanic individuals who used outpatient mental health care (Table 3). Compared with White patients, Black and Hispanic patients were significantly more likely to be ages 4–17 and single. They were also more likely to have a low family income, public insurance (for ages <65), or fair or poor perceived mental health and less likely to have a high school diploma or equivalent or to be employed (for ages <65). Compared with White patients, Black and Hispanic patients were significantly less likely to be treated for anxiety and depression, whereas Black patients were more likely than White or Hispanic patients to be treated for trauma- and stress-related disorders.
| Outpatient mental health care (%) | White-Black comparison | White-Hispanic comparison | Black-Hispanic comparison | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Characteristic | White (N=7,731) | Black (N=1,069) | Hispanic (N=1,497) | Difference (percentage points) | p | Difference (percentage points) | p | Difference (percentage points) | p |
| Age in years | |||||||||
| 4–17 | 10.6 | 17.7 | 22.0 | −7.1 | <.001 | −11.4 | <.001 | −4.3 | .060 |
| 18–44 | 32.2 | 34.9 | 37.3 | −2.7 | .260 | −5.2 | .020 | −2.5 | .400 |
| 45–64 | 32.1 | 32.5 | 25.6 | −.4 | .870 | 6.5 | <.001 | 6.9 | .010 |
| ≥65 | 25.2 | 15.0 | 15.1 | 10.2 | <.001 | 10.1 | <.001 | −.2 | .940 |
| Sex | |||||||||
| Male | 37.8 | 42.0 | 40.1 | −4.2 | .050 | −2.3 | .240 | 1.9 | .500 |
| Female | 62.2 | 58.0 | 59.9 | 4.2 | .050 | 2.3 | .240 | −1.9 | .500 |
| Marital status | |||||||||
| Married | 44.2 | 22.9 | 33.2 | 21.3 | <.001 | 11.0 | <.001 | −10.3 | <.001 |
| Separated, divorced, or widowed | 24.9 | 24.0 | 20.5 | .8 | .670 | 4.4 | .010 | 3.5 | .140 |
| Single | 22.8 | 38.1 | 28.4 | −15.3 | <.001 | −5.7 | .002 | 9.7 | .001 |
| Highest education level | |||||||||
| No high school diploma or GED | 17.8 | 32.0 | 40.6 | −14.2 | <.001 | −22.8 | <.001 | −8.6 | .004 |
| High school diploma or GED | 23.6 | 25.7 | 21.6 | −2.1 | .320 | 2.0 | .240 | 4.0 | .110 |
| Some college | 26.1 | 24.3 | 20.9 | 1.7 | .410 | 5.2 | .003 | 3.5 | .190 |
| Bachelor’s degree | 32.5 | 18.0 | 16.9 | 14.5 | <.001 | 15.6 | <.001 | 1.1 | .620 |
| Family income | |||||||||
| Poor or near poverty | 13.9 | 35.5 | 23.3 | −21.6 | <.001 | −9.3 | <.001 | 12.2 | <.001 |
| Low | 11.1 | 17.3 | 15.3 | −6.2 | .002 | −4.1 | .003 | 2.0 | .380 |
| Middle | 27.1 | 24.6 | 29.9 | 2.6 | .240 | −2.7 | .180 | −5.3 | .060 |
| High | 47.8 | 22.6 | 31.6 | 25.2 | <.001 | 16.2 | <.001 | −9.0 | .005 |
| Health insurance | |||||||||
| Private, <65 years | 57.2 | 41.1 | 52.4 | 16.1 | <.001 | 4.9 | .040 | −11.3 | .001 |
| Public, <65 years | 15.8 | 41.3 | 28.5 | −25.5 | <.001 | −12.7 | <.001 | 12.8 | <.001 |
| Uninsured | 1.8 | 2.6 | 4.1 | −.8 | .250 | −2.2 | .002 | −1.4 | .140 |
| Medicare only, ≥65 years | 9.5 | 3.6 | 5.2 | 5.9 | <.001 | 4.4 | <.001 | −1.5 | .130 |
| Medicare and public, ≥65 years | 12.6 | 6.0 | 3.0 | 6.6 | <.001 | 9.6 | <.001 | 3.0 | .004 |
| Medicare and private, ≥65 years | 3.0 | 5.3 | 6.9 | −2.3 | .005 | −3.9 | <.001 | −1.5 | .210 |
| Employment status | |||||||||
| Employed | 48.5 | 38.0 | 40.8 | 10.5 | <.001 | 7.8 | <.001 | −2.7 | .310 |
| Not employed, <65 years | 30.5 | 49.0 | 45.4 | −18.5 | <.001 | −15.0 | <.001 | 3.6 | .210 |
| Not employed, ≥65 years | 21.0 | 12.9 | 13.8 | 8.0 | <.001 | 7.2 | <.001 | −.8 | .640 |
| Treated mental health conditionb | |||||||||
| Any mood disorder | 38.1 | 33.9 | 30.7 | 4.2 | .060 | 7.4 | <.001 | 3.3 | .190 |
| Depression | 34.3 | 27.7 | 28.1 | 6.6 | .004 | 6.2 | .001 | −.4 | .870 |
| Anxiety | 41.5 | 28.5 | 34.4 | 13.0 | <.001 | 7.0 | .001 | −6.0 | .020 |
| Trauma- or stress-related disorder | 7.6 | 10.4 | 7.2 | −2.8 | .030 | .4 | .670 | 3.2 | .040 |
| ADHD or disruptive behavior disorder | 14.0 | 16.4 | 17.3 | −2.4 | .200 | −3.3 | .080 | −.9 | .730 |
| Other mental health disorder | 43.3 | 48.3 | 44.4 | −5.0 | .030 | −1.1 | .590 | 3.9 | .120 |
| Mental health–related condition | 6.9 | 10.4 | 8.1 | −3.5 | .020 | −1.2 | .330 | 2.3 | .210 |
| Perceived mental health status | |||||||||
| Excellent | 16.2 | 14.7 | 17.8 | 1.4 | .360 | −1.6 | .290 | −3.1 | .120 |
| Very good | 30.0 | 21.2 | 24.7 | 8.7 | <.001 | 5.2 | <.001 | −3.5 | .150 |
| Good | 35.0 | 35.8 | 32.9 | −.8 | .660 | 2.1 | .260 | 2.9 | .240 |
| Fair or poor | 18.9 | 28.2 | 24.5 | −9.3 | <.001 | −5.7 | <.001 | 3.7 | .180 |
a
Source: 2018–2019 Medical Expenditure Panel Survey, sample members ages ≥4 years. Black denotes non-Hispanic Black, and White denotes non-Hispanic White. Percentages are based on weighted sampling. GED, general equivalency diploma.
b
Study participants may have received outpatient mental health care for more than one mental health condition.
Psychotropic Medications and Psychotherapy
We observed several racial-ethnic differences in the use of psychotropic medications or psychotherapy (Table 4). After we controlled for age, sex, and perceived mental health status, we found that Black and Hispanic patients were significantly less likely than White patients to receive medications but were more likely to receive psychotherapy (Table 4). Black patients were also significantly more likely than Hispanic patients to receive psychotherapy.
| % using mental health service | Adjusted White-Black comparisonb | Adjusted White-Hispanic comparisonb | Adjusted Black-Hispanic comparisonb | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Mental health condition | White | Black | Hispanic | Difference (percentage points) | p | Difference (percentage points) | p | Difference (percentage points) | p |
| Any (White, N=7,731; Black, N=1,069; Hispanic, N=1,497) | |||||||||
| Any psychotropic medication | 83.4 | 69.9 | 68.4 | 12.5 | <.001 | 12.3 | <.001 | .2 | .950 |
| Any psychotherapy | 33.3 | 47.7 | 42.6 | −9.7 | <.001 | −3.7 | .040 | −6.0 | .020 |
| Both | 21.4 | 24.3 | 22.4 | .4 | .800 | 2.0 | .200 | −1.5 | .490 |
| Any mood disorder (White, N=3,049; Black, N=366; Hispanic, N=504) | |||||||||
| Any psychotropic medication | 94.3 | 84.9 | 88.5 | 8.3 | .005 | 4.7 | .020 | 3.6 | .320 |
| Any psychotherapy | 39.8 | 60.3 | 50.5 | −15.1 | <.001 | −4.7 | .150 | −10.5 | .020 |
| Both | 34.9 | 46.3 | 40.7 | −7.1 | .040 | −1.0 | .780 | −6.1 | .210 |
| Depressive disorder (White, N=2,762; Black, N=296; Hispanic, N=460) | |||||||||
| Any psychotropic medication | 93.8 | 84.8 | 89.0 | 7.9 | .020 | 3.7 | .070 | 4.2 | .270 |
| Any psychotherapy | 37.9 | 60.8 | 47.9 | −17.3 | <.001 | −4.3 | .200 | −13.0 | .006 |
| Both | 32.6 | 46.2 | 38.8 | −9.3 | .010 | −1.7 | .620 | −7.6 | .140 |
| Anxiety disorder (White, N=3,177; Black, N=315; Hispanic, N=520) | |||||||||
| Any psychotropic medication | 92.1 | 84.5 | 81.7 | 8.3 | .020 | 8.6 | <.001 | −.3 | .950 |
| Any psychotherapy | 36.5 | 47.4 | 42.6 | −8.3 | .030 | −.2 | .960 | −8.2 | .060 |
| Both | 29.9 | 35.3 | 31.0 | −2.3 | .530 | 3.3 | .260 | −5.6 | .210 |
| Trauma- or stress-related disorder (White, N=610; Black, N=103; Hispanic, N=107) | |||||||||
| Any psychotropic medication | 68.6 | 55.2 | 50.3 | 12.8 | .040 | 16.1 | .008 | −3.2 | .670 |
| Any psychotherapy | 65.2 | 70.4 | 61.5 | −3.0 | .610 | 8.1 | .140 | −11.1 | .120 |
| Both | 42.2 | 36.3 | 33.9 | 7.0 | .180 | 9.3 | .090 | −2.3 | .740 |
| ADHD or disruptive behavior disorder (White, N=1,028; Black, N=173; Hispanic, N=244) | |||||||||
| Any psychotropic medication | 93.3 | 84.0 | 75.9 | 6.8 | .100 | 14.9 | <.001 | −8.1 | .130 |
| Any psychotherapy | 37.5 | 52.1 | 50.7 | −12.0 | .050 | −13.3 | .010 | 1.3 | .870 |
| Both | 33.2 | 41.9 | 36.6 | −7.6 | .130 | −5.0 | .320 | −2.6 | .690 |
| Mental health–related condition (White, N=3,378; Black, N=519; Hispanic, N=651) | |||||||||
| Any psychotropic medication | 75.6 | 64.4 | 62.5 | 9.2 | .004 | 9.7 | .001 | −.5 | .910 |
| Any psychotherapy | 43.6 | 52.0 | 50.6 | −2.2 | .420 | −.1 | .970 | −2.1 | .530 |
| Both | 25.7 | 23.0 | 25.7 | 6.2 | .010 | 3.5 | .200 | 2.7 | .430 |
| Other mental disorder (White, N=548; Black, N=122; Hispanic, N=128) | |||||||||
| Any psychotropic medication | 81.7 | 80.2 | 73.8 | 2.4 | .660 | 9.9 | .090 | −7.5 | .310 |
| Any psychotherapy | 64.0 | 68.0 | 68.8 | −7.2 | .110 | −3.0 | .620 | −4.2 | .530 |
| Both | 52.5 | 52.6 | 48.8 | −1.9 | .740 | 6.7 | .290 | −8.6 | .300 |
a
Source: 2018–2019 Medical Expenditure Panel Survey, sample members ages ≥4 years. Black denotes non-Hispanic Black, and White denotes non-Hispanic White. Percentages are based on weighted sampling.
b
Adjusted for age (as categorical variable), sex, and perceived mental health status.
In line with this overall pattern, Black patients who were treated for depression or other mood disorders, anxiety, trauma- or stress-related disorders, or mental health–related conditions were less likely than White patients to receive psychotropic medications. However, Black patients treated for depression or other mood disorders, anxiety, or ADHD or disruptive behavior disorders were significantly more likely than White patients to receive psychotherapy. Black patients treated for depression or other mood disorders were also significantly more likely than White patients to receive both psychotherapy and psychotropic medications.
Compared with White patients, Hispanic patients treated for mood, anxiety, or trauma- or stress-related disorders; ADHD or disruptive behavior disorders; or mental health–related conditions were less likely to receive a psychotropic medication (Table 4). Hispanic patients treated for ADHD or disruptive behavior disorders were significantly more likely than White patients to receive psychotherapy. Finally, Black patients who were treated for depression were more likely than Hispanic patients to receive psychotherapy.
Psychotropic Medications and Minimally Adequate Treatment
After we controlled the analysis for age, sex, and perceived mental health status, among patients treated for depression, White patients were significantly more likely than Black or Hispanic patients to receive antidepressants (Table 5). These differences persisted after we also controlled for health care coverage (see Table S4 in the online supplement ). Compared with White patients treated for depression, Black patients were more likely to receive antipsychotic medications, and this difference persisted after we controlled for health care coverage. No significant racial-ethnic differences were found in the percentages of patients who received minimally adequate treatment.
| % receiving treatment | Adjusted White-Black comparisonb | Adjusted White-Hispanic comparisonb | Adjusted Black-Hispanic comparisonb | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Mental health condition | White | Black | Hispanic | Difference (percentage points) | p | Difference (percentage points) | p | Difference (percentage points) | p |
| Depressive disorder (White, N=2,762; Black, N=296; Hispanic, N=460) | |||||||||
| Any antidepressant | 89.4 | 73.2 | 80.9 | 13.6 | .001 | 6.6 | .010 | −7.0 | .100 |
| Any anxiolytic/sedative | 27.3 | 22.2 | 29.9 | 5.4 | .090 | −2.2 | .490 | −7.6 | .080 |
| Any antipsychotic | 10.8 | 24.4 | 14.7 | −10.9 | .002 | −2.5 | .420 | 8.4 | .080 |
| Minimally adequate treatmentc | 30.7 | 40.5 | 36.0 | −6.7 | .080 | −2.0 | .510 | 4.6 | .330 |
| Anxiety disorder (White, N=3,177; Black, N=315; Hispanic, N=520) | |||||||||
| Any antidepressant | 76.2 | 58.7 | 58.5 | 17.9 | <.001 | 16.0 | <.001 | −1.9 | .670 |
| Any anxiolytic/sedative | 40.5 | 42.4 | 46.2 | −.3 | .940 | −7.2 | .030 | −6.9 | .200 |
| Any antipsychotic | 10.2 | 19.2 | 13.7 | −6.4 | .020 | −2.5 | .360 | 4.0 | .300 |
| Minimally adequate treatmentc | 30.7 | 36.7 | 33.3 | −3.9 | .280 | 2.5 | .380 | 6.5 | .130 |
| ADHD or disruptive behavior disorder (White, N=1,028; Black, N=173; Hispanic, N=244) | |||||||||
| Any stimulantd | 86.2 | 80.1 | 71.9 | 3.9 | .410 | 13.9 | .001 | 10.1 | .090 |
| Any anxiolytic/sedative | 10.6 | 10.8 | 6.7e | −2.6 | .380 | .2 | .950 | 2.8 | .460 |
| Any antipsychotic | 10.7 | 15.2 | 10.5e | −2.5 | .560 | −.8 | .810 | 1.8 | .710 |
| Minimally adequate treatmentc | 36.9 | 42.3 | 35.3 | −1.0 | .850 | 4.0 | .300 | 5.0 | .420 |
a
Source: 2018–2019 Medical Expenditure Panel Survey, sample members ages ≥4 years. Black denotes non-Hispanic Black, and White denotes non-Hispanic White. Percentages are based on weighted sampling.
b
Adjusted for age (as categorical variable), sex, and perceived mental health status.
c
Defined as at least eight visits to a mental health provider with or without medications or at least four visits to any provider and receipt of an antidepressant (depressive disorder), antidepressant or anxiolytic/sedative (anxiety disorder), or stimulant or other ADHD medication (ADHD and disruptive behavior disorder).
d
Includes stimulants and other ADHD medications.
e
Unreliable estimate (relative standard error >0.3).
Among patients treated for anxiety disorders, White patients were more likely than Black or Hispanic patients to receive antidepressants, and these differences endured after adjustment for perceived mental health status and health care coverage (Table 5). However, White patients who were treated for anxiety were less likely than Black patients to receive antipsychotic medications, but not after we also controlled for health care coverage. White patients treated for anxiety disorders were less likely than Hispanic patients to receive anxiolytics or sedatives, but not after we also controlled for health care coverage (see Table S4 in the online supplement ). White patients treated for ADHD or disruptive behavior disorders were significantly more likely than Hispanic patients to receive stimulants or other ADHD medications, including after we controlled for health care coverage (see Table S4 in the online supplement ).
Discussion
Our findings reveal that in the United States, Black and Hispanic individuals were less than half as likely as White individuals to receive any outpatient mental health care service in a given year. These gaps in service use, which are broadly consistent with observations from earlier epidemiological surveys (1, 2), were evident across different age groups and both sexes, persisted after we controlled for several potentially confounding socioeconomic factors, and highlight the need for renewed efforts to improve mental health service access for Black and Hispanic people. Beyond marked racial-ethnic differences in access to care, Hispanic, Black, and White people also differed in their likelihood of receiving psychotherapy and psychotropic medications. Contrary to our expectations, however, for several common mental disorders, these groups did not significantly differ in their likelihood of receiving minimally adequate treatment once treatment was initiated. However, persisting racial-ethnic gaps in access to mental health care underscore the need for service reforms to facilitate greater access to timely, appropriate, and high-quality mental health care that is tailored to the culture and context of each patient.
As a result of unjust social and economic policies and practices (3), substantial socioeconomic differences exist among Black, Hispanic, and White individuals who receive outpatient mental health care in the United States. Relative to White patients, Black and Hispanic patients tended to be younger and to have less education, have lower incomes, and lack employment and were more likely to have public health insurance. Because many mental health specialists (23), including most psychiatrists (24), do not accept patients with Medicaid, socioeconomic disadvantages disproportionately restrict the mental health care options available to Black and Hispanic patients.
Among patients receiving treatment for depression, anxiety, or ADHD or disruptive behavior disorders, no significant racial-ethnic differences were found in the likelihood of receiving minimally adequate treatment. Previous reports of Black and Hispanic individuals having lower likelihoods than White individuals of receiving minimally adequate mental health treatment (8–10) were likely driven primarily by racial-ethnic differences in access to any outpatient mental health care and only to a lesser extent by differences in service patterns after treatment initiation. These patterns underscore the central importance of maintaining a focus on expanding service accessibility to underserved racial-ethnic groups. Yet, low rates of receiving even minimally adequate care across racial-ethnic groups also raise broader concerns about general deficiencies in the quality and effectiveness of community mental health care. Consistent with pervasive suboptimal care, one nationally representative study recently reported that only 45% of White, 32% of Black, and 28% of Hispanic U.S. adults who were receiving antidepressants for depression were in symptomatic remission (25).
Among individuals receiving outpatient mental health care, Black and Hispanic patients tended to be less likely than White patients to receive psychotropic medications and more likely to receive psychotherapy. Beyond a general population-wide preference for psychotherapy over pharmacological treatments (26), Black people, and to a lesser extent Hispanic people, prefer psychotherapy over medications for the treatment of depression more often than do White people (27–29). These differences may be partially mediated by racial-ethnic differences in attitudes concerning the etiology of depression, the safety and effectiveness of antidepressants and psychotherapy, and the role of prayer and spirituality in coping with an episode of depression (23). Because accommodating patient preferences is related to improved treatment adherence and outcomes (30), the broad alignment of racial-ethnic preferences with observed treatment patterns may capture a degree of responsiveness of clinical services to patients’ preferences. Adapting mental health care to patients’ cultural values and contexts has also been found to increase use and improve outcomes (31).
Among patients treated for depression or anxiety, Black patients were more likely than White patients to receive antipsychotic medications. In line with this finding, Black patients with Medicaid who initiated treatment for major depressive disorder have also been found to be significantly more likely than White patients with Medicaid to receive antipsychotic medications (32). The metabolic risks of antipsychotic medications and their small-to-modest effects as adjunctive treatments for major depressive disorder (33) have prompted concerns regarding overuse of these medications (34). Higher rates of obesity and diabetes among Black patients, compared with White patients (35, 36), compound these safety concerns for Black patients and highlight the need to probe the basis of this racial-ethnic variation in pharmacological treatment. Specifically, it is important to evaluate the extent to which differences between Black and White patients in antipsychotic treatment for nonpsychotic disorders represent an appropriate response to variation in illness severity or comorbid diagnoses (32) or reflect biased clinical overvaluation of psychotic symptoms among Black patients with mood disorders (37). This currently unexplained difference is a potential target for quality improvement efforts.
In treatment for ADHD or disruptive behavior disorders, Hispanic patients were significantly less likely than White patients to receive stimulants or other ADHD medications. Previous research has documented similar patterns for children (38). Mental health professionals may be able to better serve Hispanic parents and children by developing partnerships with schools, churches, and traditional healers from whom these individuals may initially seek care (39) and by implementing culturally sensitive mental health interventions (40). Consistent with an analysis of Medicaid claims (41), Black and Hispanic patients with ADHD were more likely than White patients to receive psychotherapy. Because psychotherapy tends to yield smaller effects than stimulants in reducing ADHD symptoms (42), it is important that all patients and their families be provided with relevant clinical information to make informed choices about available ADHD treatments.
Our analyses had several limitations. First, the MEPS relies on respondent recall and diaries that may underestimate mental health care in a manner that varies across racial-ethnic groups. Second, diagnoses in MEPS are based on respondent reports and are not subject to expert validation. Third, the perceived mental health status measure is only modestly correlated with symptoms of psychological distress (43), and this correlation may vary by racial-ethnic group (44) because of differences in mental health literacy, cultural attitudes, stigma, or other factors. Fourth, children and adults, who were combined into a single group to ensure sufficient statistical power, vary in their mental health treatment patterns. Fifth, the analyses did not capture important regional variations in policies, resources, or social conditions that play a central role in health disparities (45). Sixth, left and right censoring related to the survey year truncated some treatment episodes. Finally, the MEPS provides no information on clinical outcomes, and it is therefore not possible to evaluate associations among race-ethnicity, the adequacy of care, and mental health outcomes.
Conclusions
Large national racial-ethnic differences in use of mental health services underscore persistent disparities in service access. Structural racism (46), cultural attitudes, and racial-ethnic biases in clinical recognition of mental health problems likely contribute to low rates of mental health treatment among Black and Hispanic individuals. Although significant racial-ethnic differences were also evident in the treatments received after patients entered mental health treatment, meaningful progress in narrowing racial-ethnic differences in mental health service delivery will require dedicated efforts to promote service access for underserved minority groups. These efforts may necessitate developing culturally centered integrated primary care and specialty mental health services that help nurture trusting patient-provider partnerships in environments that respect and appreciate patients’ ethnic and cultural diversity. Advocacy may also be required to address deep structural factors, such as the shortage of psychiatrists in areas that have high proportions of Black and Hispanic individuals (47), which may perpetuate racial-ethnic inequities in access to mental health care.
Supplementary Material
File (appi.ps.20220365.ds001.docx)
- Download
- 35.13 KB
References
1.
Cook BL, Zuvekas SH, Chen J, et al: Assessing the individual, neighborhood, and policy predictors of disparities in mental health care. Med Care Res Rev 2017; 74:404–430
2.
Ault-Brutus A, Alegria M: Racial/ethnic differences in perceived need for mental health care and disparities in use of care among those with perceived need in 1990–1992 and 2001–2003. Ethn Health 2018; 23:142–157
3.
Shim RS: Dismantling structural racism in psychiatry: a path to mental health equity. Am J Psychiatry 2021; 178:592–598
4.
Alvidrez JL, Barksdale CL: Perspectives from the National Institutes of Health on multidimensional mental health disparities research: a framework for advancing the field. Am J Psychiatry 2022; 179:417–421
5.
Williams DR, Mahommed SA: Racism and health I: pathways and scientific evidence. Am Behav Scientist 2013; 57:1152–1173
6.
Lu W, Muñoz-Laboy M, Sohler N, et al: Trends and disparities in treatment for co-occurring major depression and substance use disorders among US adolescents from 2011 to 2019. JAMA Netw Open 2021; 4:e2130280
7.
Holden K, McGregor B, Thandi P, et al: Toward culturally centered integrative care for addressing mental health disparities among ethnic minorities. Psychol Serv 2014; 11:357–368
8.
Young AS, Klap R, Sherbourne CD, et al: The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001; 58:55–61
9.
Wang PS, Berglund P, Kessler RC: Recent care of common mental disorders in the United States: prevalence and conformance with evidence-based recommendations. J Gen Intern Med 2000; 15:284–292
10.
Ault-Brutus AA: Changes in racial-ethnic disparities in use and adequacy of mental health care in the United States, 1990–2003. Psychiatr Serv 2012; 63:531–540
11.
Narain K, Xu H, Azocar F, et al: Racial/ethnic disparities in specialty behavioral health care treatment patterns and expenditures among commercially insured patients in managed behavioral health care plans. Health Serv Res 2019; 54:575–585
12.
Weiss C, Connor S, Ward P, et al: Report on Interim Nonresponse Subsampling of MEPS Panel 16. Working paper no 13001. Rockville, MD, Agency for Healthcare Research and Quality, 2013
13.
MEPS HC-036BRR: 1996–2019 Replicate File for BRR Variance Estimation. Rockville, MD, Agency for Healthcare Research and Quality, Center for Financing, Access, and Cost Trends, 2021. meps.ahrq.gov/data_stats/download_data/pufs/h036brr/h36brr19doc.shtml. Accessed Dec 7, 2022
14.
Manseau M, Case BG: Racial-ethnic disparities in outpatient mental health visits to US physicians, 1993–2008. Psychiatr Serv 2014; 65:59–67
15.
Pingitore D, Snowden L, Sansone RA, et al: Persons with depressive symptoms and the treatments they receive: a comparison of primary care physicians and psychiatrists. Int J Psychiatry Med 2001; 31:41–60
16.
Miranda J, Cooper LA: Disparities in care for depression among primary care patients. J Gen Intern Med 2004; 19:120–126
17.
MEPS Survey Questionnaires. Rockville, MD, Agency for Healthcare Research and Quality, Center for Financing, Access, and Cost Trends, 2022. meps.ahrq.gov/mepsweb/survey_comp/survey.jsp#Questionnaires. Accessed Dec 7, 2022
18.
Machlin S, Cohen J, Elixhauser A, et al: Sensitivity of household reported medical conditions in the Medical Expenditure Panel Survey. Med Care 2009; 47:618–625
19.
Cook BL, Zuvekas SH, Carson N, et al: Assessing racial-ethnic disparities in treatment across episodes of mental health care. Health Serv Res 2014; 49:206–229
20.
Cook BL, McGuire TG, Zaslavsky AM: Measuring racial/ethnic disparities in health care: methods and practical issues. Health Serv Res 2012; 47:1232–1254
21.
McGuire TG, Alegria M, Cook BL, et al: Implementing the Institute of Medicine definition of disparities: an application to mental health care. Health Serv Res 2006; 41:1979–2005
22.
Flanagin A, Frey T, Christiansen SL, et al: Updated guidance on the reporting of race and ethnicity in medical and science journals. JAMA 2021; 326:621–627
23.
McKenna RM, Pintor JK, Ali MM: Insurance-based disparities in access, utilization, and financial strain for adults with psychological distress. Health Aff 2019; 38:826–834
24.
Bishop TF, Press MJ, Keyhani S, et al: Acceptance of insurance by psychiatrists and the implications for access to mental health care. JAMA Psychiatry 2014; 71:176–181
25.
Mojtabai R, Amin-Esmaeili M, Spivak S, et al: Remission and treatment augmentation of depression in the United States. J Clin Psychiatry 2021; 82:21m13988
26.
McHugh RK, Whitton SW, Peckham AD, et al: Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review. J Clin Psychiatry 2013; 74:595–602
27.
Givens JL, Houston TK, Van Voorhees BW, et al: Ethnicity and preferences for depression treatment. Gen Hosp Psychiatry 2007; 29:182–191
28.
Cooper LA, Gonzales JJ, Gallo JJ, et al: The acceptability of treatment for depression among African-American, Hispanic, and White primary care patients. Med Care 2003; 41:479–489
29.
Silverman AL, Werntz A, Ko TM, et al: Implicit and explicit beliefs about the effectiveness of psychotherapy vs medication: a large-scale examination and replication. J Nerv Ment Dis 2021; 209:783–795
30.
Windle E, Tee H, Sabitova A, et al: Association of patient treatment preference with dropout and clinical outcomes in adult psychosocial mental health interventions: a systematic review and meta-analysis. JAMA Psychiatry 2020; 77:294–302
31.
Griner D, Smith TB: Culturally adapted mental health intervention: a meta-analytic review. Psychotherapy 2006; 43:531–548
32.
Gerhard T, Stroup TS, Correll CU, et al: Antipsychotic medication treatment patterns in adult depression. J Clin Psychiatry 2018; 79:16m10971
33.
Nelson JC, Papakostas GI: Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials. Am J Psychiatry 2009; 166:980–991
34.
Spielmans GI, Berman MI, Linardatos E, et al: Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes. PLoS Med 2013; 10:e1001403
35.
Cheng YJ, Kanaya AM, Araneta MRG, et al: Prevalence of diabetes by race and ethnicity in the United States, 2011–2016. JAMA 2019; 322:2389–2398
36.
Hales CM, Fryar CD, Carroll MD, et al: Differences in obesity prevalence by demographic characteristics and urbanization level among adults in the United States, 2013–2016. JAMA 2018; 319:2419–2429
37.
Gara MA, Vega WA, Arndt SA, et al: Influence of patient race and ethnicity on clinical assessment in patients with affective disorders. Arch Gen Psychiatry 2012; 69:593–600
38.
Walls M, Allen CG, Cabral H, et al: Receipt of medication and behavioral therapy among a national sample of school-age children diagnosed with attention-deficit/hyperactivity disorder. Acad Pediatr 2018; 18:256–265
39.
Lawton KE, Gerdes AC, Haack LM, et al: Acculturation, cultural values, and Latino parental beliefs about the etiology of ADHD. Adm Policy Ment Health 2014; 41:189–204
40.
Gerdes AC, Kapke TL, Hurtado GD, et al: Culturally adapting parent training for Latino youth with ADHD: development and pilot. J Latina/o Psychol 2015; 392:71–87
41.
Cummings JR, Ji X, Allen L, et al: Racial and ethnic differences in ADHD treatment quality among Medicaid-enrolled youth. Pediatrics 2017; 139:e20162444
42.
Van der Oord S, Prins PJM, Oosterlaan J, et al: Efficacy of methylphenidate, psychosocial treatments and their combination in school aged children with ADHD: a meta-analysis. Clin Psychol Rev 2008; 28:783–800
43.
Fleishman JA, Zuvekas SH: Global self-rated mental health: associations with other mental health measures and with role functioning. Med Care 2007; 45:602–609
44.
Zuvekas SH, Fleishman JA: Self-rated mental health and racial/ethnic disparities in mental health service use. Med Care 2008; 46:915–923
45.
Lett E, Asabor E, Beltrán S, et al: Conceptualizing, contextualizing, and operationalizing race in quantitative health sciences research. Ann Fam Med 2022; 20:157–163
46.
Mensah M, Ogbu-Nwobodo L, Shim RS: Racism and mental health equity: history repeating itself. Psychiatr Serv 2021; 72:1091–1094
47.
Dinwiddie GY, Gaskin DJ, Chan KS, et al: Residential segregation, geographic proximity and type of services used: evidence for racial/ethnic disparities in mental health. Soc Sci Med 2013; 80:67–75
Information & Authors
Information
Published In
History
Received: 15 July 2022
Revision received: 17 September 2022
Revision received: 21 October 2022
Accepted: 2 November 2022
Published online: 4 January 2023
Published in print: July 01, 2023
Keywords
Authors
Competing Interests
The authors report no financial relationships with commercial interests.
Funding Information
The views expressed in this article are those of the authors, and no official endorsement by the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services is intended or should be inferred.
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
View Options
View options
PDF/EPUB
View PDF/EPUBLogin options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).